CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
HealOS (formerly Scribehealth.ai) is Now HealOS.ai: A New Era of Healthcare Automation

From HealOS Blog

October 2, 2025

HealOS (formerly Scribehealth.ai) is Now HealOS.ai: A New Era of Healthcare Automation

HealOS (formerly Scribehealth.ai) is Now HealOS.ai: A New Era of Healthcare Automation
HealOS announced its rebrand from Scribehealth.ai to HealOS.ai, marking an expansion from just AI medical scribing to a full healthcare automation platform. The company secured .2 million in funding to ramp up development and reach more clinicians. HealOS now offers six AI agents covering the entire practice workflow: AI Scribe, AI Receptionist, Benefits Verification, Prior Authorization, Fax and Referrals, and Billing/RCM. The platform serves 5,000+ patients across 7 clinics, handling 12,000+ visits/month and has saved 3,200+ hours since 2024 deployment.

View original article on healos.ai

Most Recent

Broadcom adds hypervisor protection to VMware

Citing the growing speed and volume of artificial intelligence-enabled attacks, Broadcom Inc. today introduced VMware HyperArmor, software that protects the hypervisor underlying VMware Cloud Foundation and gives administrators more time to test and deploy security patches. Announced at VMware Explo

Oct 13, 2026

Character.AI files for Chapter 11 bankruptcy in the US, agrees to sell some assets to Disney for $20M, and plans to keep operating as it completes the sale

Character.AI said on Monday it had filed for Chapter 11 bankruptcy in the US and agreed to sell some of its assets to Walt Disney (DIS.N) for $20 million.

Oct 12, 2026

Nvidia's AI chip shipments in China fell 44% YoY to 678K in H1 2026, as its market share slid to 34% amid US export curbs and rising domestic competition

Nvidia's (NVDA.O) share of China's market for data-centre AI chips fell to 34% in the first half of 2026, as US export controls restricted supplies …

Oct 12, 2026

NTT to build first data center for Anthropic in Japan

TOKYO/OSAKA — NTT Data Group is in the final stages of talks to build a data center in western Japan for U.S. AI company Anthropic, multiple sources have told Nikkei.

Oct 12, 2026

Similar Posts

Hippocratic is building a large language model for healthcare

AI, specifically generative AI, has the potential to transform healthcare. At least, that sales pitch from Hippocratic Health, which emerged from stealth today with a whopping $50 million in seed financing behind it and a valuation in the “triple digit millions.” The tranche, co-led by General Catalyst and Andreessen Horowitz, is a big vote of […]

May 16, 2023

Notable Raises M Series B to Expand Intelligent Automation in Healthcare

Notable Health announces million Series B funding round led by ICONIQ Growth to expand its intelligent automation platform for healthcare.

Nov 2, 2021

Heidi Launches Evidence and Acquires AutoMedica to Accelerate Its AI Care Partner Platform

Heidi announced the launch of Heidi Evidence and the acquisition of UK-based clinical AI company AutoMedica, marking its evolution from an AI scribe into a comprehensive AI Care Partner platform.

Feb 23, 2026

Notable and CityMD Announce Multi-Year Partnership to Transform Patient Access with AI and Automation

Notable, the AI platform purpose-built for healthcare, and CityMD, one of the largest urgent care providers in the United States, announced a multi-year partnership to deploy Notable's AI Agents across more than 180 CityMD locations, transforming patient access and reducing administrative burden at scale.

Mar 18, 2025